Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4028720015 | Tafasitamab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4028721016 | Tafasitamab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tafasitamab (substance) | est un(e) (attribut) | Monoclonal antibody (substance) | true | Inferred relationship | Some | ||
| Tafasitamab (substance) | est un(e) (attribut) | Antineoplastic agent (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tafasitamab-containing product | a pour principe actif (attribut) | True | Tafasitamab (substance) | Inferred relationship | Some | 1 |
| Product containing only tafasitamab (medicinal product) | a pour principe actif (attribut) | True | Tafasitamab (substance) | Inferred relationship | Some | 1 |
| Product containing only tafasitamab in parenteral dose form (medicinal product form) | a pour principe actif (attribut) | True | Tafasitamab (substance) | Inferred relationship | Some | 1 |
| Product containing tafasitamab in parenteral dose form (medicinal product form) | a pour principe actif (attribut) | True | Tafasitamab (substance) | Inferred relationship | Some | 1 |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR